Key points from article :
MeiraGTx is developing gene therapies for diseases like blindness, cancer, and obesity.
Their gene therapy replaces faulty genes with healthy ones, similar to treating haemophilia.
CEO Zandy Forbes told that they're working on "gene regulation" tech, a pill that switches genes on or off to kickstart immune system.
Their lead program treats X-linked retinitis pigmentosa, restoring vision in patients.
For cancer, they aim to turn the body into a drug factory with gene therapy pills.
Gene regulation could also target obesity by activating genes controlling appetite and satiety.
Meira's unique lab combines research and manufacturing for efficiency and collaboration.
Forbes hopes their technology can revolutionize disease treatment affordability and effectiveness.
